Daxor to showcase new HFSA clinical data on blood volume analysis in advanced heart failure patients
Bitget2026/10/01 12:03- Daxor flagged new independent clinical data on blood-volume measurement in advanced heart failure, scheduled for presentation at HFSA 2026.
- Findings are expected to show the test can identify clinically meaningful fluid-status patterns missed by standard assessment methods.
- Management framed the data as support for broader adoption of its next-generation Blood Volume Analyzer across hospitals, aiming to reduce readmissions.
- The FDA 510(k)-cleared system is positioned as a faster workflow tool that uses a smaller blood draw, targeting easier routine clinical use.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Bank of Japan minutes turn hawkish: Most members believe a rate hike is needed soon, with a 70% probability of a hike in December
Minutes from the Bank of Japan show that several members believe a rate hike is needed in the near term, with a roughly 70% probability of an increase in December. Core inflation has met the target for the first time in 30 years, and the current policy rate stands at 1.25%.
Former Chainlink Product Marketing Director Michael Robinson joins Monad Foundation
The Federal Reserve Eyes $1.8 Trillion in “Shadow Credit”: Dallas and New York Fed Launch First Private Credit Survey
The Dallas and New York Federal Reserves have launched an investigation into private credit lending standards, covering an industry worth 1.8 trillions USD, with a minimum threshold of 50 millions USD. The results will be released in the first quarter of 2027.
Tom Lee Says a VIX Signal Points to a Stock Market Bottom
Crypto prices
More
